Newtag icon
Top Black Friday 2025 brands announced! What were the hottest products and categories?Download the report now 👉banner icon
Alkermes

November 2025

Alkermes Market Share Analysis for November 2025

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall.
Year Founded1987
Employees1001 - 5000
Annual Revenue> $1B
alkermes.com
Alkermes
Alkermes (including company regionals)
  • alkermes.com
    alkermes.com
See more website traffic and engagement information

Alkermes Revenue up to November 2025 is > 1B

revenue generated by Alkermes top domains

Alkermes top domains revenue over 3 years

Revenue for Alkermes top domains


Total visits to Alkermes's top domains

Understand Alkermes market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Alkermes's top domains

Analyze Alkermes engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Alkermes's top domains

See how Alkermes keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Alkermes

These are the website technologies, by industry, used by Alkermes top domains

Advertising (7)

Google Adsense

Google Adsense

Conversion & Analytics (3)

Google Analytics

Google Analytics

Marketing (3)

Google Marketing Platform

Google Marketing Platform

Audio Video Media (2)

YouTube

YouTube

More Technologies

8

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Alkermes

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlkermes, Inc. acquires Avadel Pharmaceuticals plc.Alkermes on Wednesday said it has agreed to purchase Ireland-based Avadel Pharmaceuticals for $18.50 per share, reflecting a 3.5% premium to the latter company's closing share price the day prior.
NewsAlkermes, Inc. has issues with antitrust lawsuit over alleged scheme to block generic versions of Vivitrol.Alkermes faces antitrust lawsuit over alleged scheme to block generic versions of Vivitrol (no ratings yet).

See all Alkermes signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.